Who Paid My Doc Search
Menu
Organisation paid for research Program year 2024 Source: CMS Open Payments

Cenexel

Neither a doctor nor a teaching hospital

Research payments

$542,614

18 payments

Through program year 2024, Cenexel is reported as receiving $542,614 in research payments, across 18 payments.

By program year

2 rows
Year Kind Amount Payments
2024 Research $99,207 1
2022 Research $443,406 17

Breakdown

Who paid Research payments · program years 2022–2024
  1. Sumitomo Dainippon Pharma Co., Ltd. $442,982 13 payments
  2. Amgen Inc. $99,207 1 payment
  3. Rhythm Pharmaceuticals, Inc. $424 4 payments
Studies the money was for Research payments · program years 2022–2024
  1. Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjects $442,982 13 payments
  2. AMG 133 Titration PK Tolerability $99,207 1 payment
  3. Rm-493-034 $424 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record